PT  - JOURNAL ARTICLE
AU  - Gurjit Kaur
AU  - Lilian Gonsalves
AU  - Holly L. Thacker
TI  - Premenstrual dysphoric disorder: A review for the treating practitioner
DP  - 2004 Apr 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 303--321
VI  - 71
IP  - 4
4099  - http://www.ccjm.org/content/71/4/303.short
4100  - http://www.ccjm.org/content/71/4/303.full
SO  - Cleve Clin J Med2004 Apr 01; 71
AB  - Premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome (PMS), is characterized by physical and behavioral symptoms that cause marked social impairment during the last half of the menstrual cycle. Symptoms are believed to result from the interaction of central neurotransmitters and normal menstrual hormonal changes. Treatment usually begins with lifestyle changes, over-the-counter medications, and if needed, selective serotonin reup-take inhibitors. Physicians should be aware of the risks of many of the alternative therapies commonly touted in the popular press.